Androgen receptor stops tumor growth in the most common form of breast cancer

(The Endocrine Society) Researchers say they have found a viable new therapeutic strategy for estrogen receptor-positive (ER+) breast cancer, even cancers that are resistant to current standard of care treatments. They will present the results of their new preclinical study accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news